Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study

Chow, Clara K and Ramasundarahettige, Chinthanie and Hu, Weihong and AlHabib, Khalid F and Avezum, Alvaro and Cheng, Xiaoru and Chifamba, Jephat and Dagenais, Gilles and Dans, Antonio and Egbujie, Bonaventure A and Gupta, Rajeev and Iqbal, Romaina and Ismail, Noorhassim and Keskinler, Mirac V and Khatib, Rasha and Kruger, Lanthé and Kumar, Rajesh and Lanas, Fernando and Lear, Scott and Lopez-Jaramillo, Patricio and McKee, Martin and Mohammadifard, Noushin and Mohan, Viswanathan and Mony, Prem and Orlandini, Andres and Rosengren, Annika and Vijayakumar, Krishnapillai and Wei, Li and Yeates, Karen and Yusoff, Khalid and Yusuf, Rita and Yusufali, Afzalhussein and Zatonska, Katarzyna and Zhou, Yihong and Islam, Shariful and Corsi, Daniel and Rangarajan, Sumathy and Teo, Koon and Gerstein, Hertzel C and Yusuf, Salim and Mohan, V (2018) Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. The Lancet Diabetes & Endocrinology, 6 (10). p. 798. ISSN 22138587

Preview

PDF
319Kb

Abstract

Background Data are scarce on the availability and affordability of essential medicines for diabetes. Our aim was to examine the availability and affordability of metformin, sulfonylureas, and insulin across multiple regions of the world and explore the effect of these on medicine use.

Item Type:	Article
Official URL/DOI:	http://dx.doi.org/10.1016/S2213-8587(18)30233-X
Uncontrolled Keywords:	PURE;
Subjects:	Diabetes Epidemiology
Divisions:	Department of Epidemiology Department of Diabetology
ID Code:	1113
Deposited By:	surendar radha
Deposited On:	12 Dec 2018 15:04
Last Modified:	12 Dec 2018 15:04

Repository Staff Only: item control page